首页> 外国专利> IMMUNOGENIC COMPOSITION COMPRISING RECOMBINAT VECTOR, RECOMBINAT CELL, TRANSDUCED WITH THE RECOMBINAT VECTOR AND A VECTOR

IMMUNOGENIC COMPOSITION COMPRISING RECOMBINAT VECTOR, RECOMBINAT CELL, TRANSDUCED WITH THE RECOMBINAT VECTOR AND A VECTOR

机译:包含重组矢量,重组细胞和重组矢量及矢量的免疫原性组成

摘要

The invention relates to an immunogenic composition comprising a recombinant vector characterized in that it comprises a polynucleotide comprising the cis-acting central initiation region (cPPT) and the cis-acting termination region (CTS), these regions being of retroviral or retroviral-like origin, said vector comprising in addition a defined nucleotide sequence (transgene or sequence of interest) and regulatory signals of retrotranscription, expression and encapsidation of retroviral or retroviral-like origin, wherein the composition is capable of inducing or of stimulating a cell-mediated response for instance a CTL (Cytotoxic T Lymphocytes) response or a CD4 response, against one or several epitopes encoded by the transgene sequence present in the vector.
机译:本发明涉及包含重组载体的免疫原性组合物,其特征在于其包含包含顺式作用中央起始区(cPPT)和顺式作用终止区(CTS)的多核苷酸,这些区域是逆转录病毒或逆转录病毒样来源的,所述载体另外包含限定的核苷酸序列(转基因或目的序列)和逆转录病毒或逆转录病毒样来源的逆转录,表达和衣壳化的调节信号,其中所述组合物能够诱导或刺激细胞介导的针对其的应答。例如针对由载体中存在的转基因序列编码的一个或几个表位的CTL(细胞毒性T淋巴细胞)应答或CD4应答。

著录项

  • 公开/公告号IL204703D0

    专利类型

  • 公开/公告日2010-11-30

    原文格式PDF

  • 申请/专利号IL20100204703

  • 发明设计人

    申请日2010-03-24

  • 分类号C12N15/09;A61K35/76;A61K39;A61K39/02;A61K39/04;A61K48;A61P31;A61P31/12;A61P35;C07K14/35;C12N5/10;C12N7;C12N7/01;C12N15/86;C12N15/867;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号